Vertex Pharmaceuticals · 1 week ago
Biostatistics Associate Director (Hybrid)
Boston, MA
Full-time
Hybrid
Senior Level, Lead/Staff, Director/Executive
$165K/yr - $247K/yr
7+ years expVertex Pharmaceuticals is a global biotechnology company that invests in scientific innovation. The Associate Director, Biostatistics will conduct sophisticated statistical analyses for clinical trials and lead biostatistics projects while providing technical guidance to cross-functional teams.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Conducts all scientific and operational statistical work for multiple clinical trials, observational studies, or real world data (RWD) investigations
Leads biostatistics projects or major components of a project including work allocation and review
May include presentation to the Peer Protocol Review Committee (PPRC) or other internal senior review boards
Possesses an advanced and in-depth understanding of modern drug discovery and development processes
Represents Biostatistics as a member of cross functional teams, providing input and specialized technical guidance to elicit meaningful and/or productive outcomes
Authors study Statistical Analysis Plans (SAPs), including table, figure, and listing (TFL) shells
Develops Cross-functional Data Review (xFDR) plan, Key Reports Memo (KRM), and Data Dissemination Plan (DDP) in order to facilitate the review, summary, and dissemination of key study data/results
Qualification
Required
Conducts all scientific and operational statistical work for multiple clinical trials, observational studies, or real world data (RWD) investigations
Leads biostatistics projects or major components of a project including work allocation and review
May include presentation to the Peer Protocol Review Committee (PPRC) or other internal senior review boards
Possesses an advanced and in-depth understanding of modern drug discovery and development processes
Represents Biostatistics as a member of cross functional teams, providing input and specialized technical guidance to elicit meaningful and/or productive outcomes
Authors study Statistical Analysis Plans (SAPs), including table, figure, and listing (TFL) shells
Develops Cross-functional Data Review (xFDR) plan, Key Reports Memo (KRM), and Data Dissemination Plan (DDP) in order to facilitate the review, summary, and dissemination of key study data/results
In-depth competence with SAS and R statistical software
In-depth understanding of advanced statistical methods used in drug development
Ability to show critical thinking with logical problem-solving
Excellent written and verbal communication skills
Excels in a team environment
Collaborates well with non-statisticians
NDA/MAA experience and direct dealings with USA/European regulators
Ph. D. or master's degree in Statistics or Biostatistics
Typically requires 7 years of experience with a Ph.D
Benefits
Annual bonus
Annual equity awards
Overtime pay
Medical benefits
Dental benefits
Vision benefits
Generous paid time off
Educational assistance programs including student loan repayment
Generous commuting subsidy
Matching charitable donations
401(k)
Company
Vertex Pharmaceuticals
Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.
5001-10000 employees
H1B Sponsorship
Vertex Pharmaceuticals has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (188)
2024 (150)
2023 (111)
2022 (164)
2021 (112)
2020 (80)
Funding
Current Stage
Public CompanyTotal Funding
$657.31MKey Investors
Janssen Belgium
2024-07-10Post Ipo Secondary· $1.11M
2022-05-17Post Ipo Equity· $50M
2009-12-03Post Ipo Equity· $443M
Leadership Team
Reshma Kewalramani
CEO and President
Nina Devlin
Senior Vice President, Chief Communications Officer
Recent News
2026-01-05
2026-01-05
Company data provided by crunchbase